Spectrum of pathogenic mitochondrial DNA mutations and clinical features in Japanese families with Leber's hereditary optic neuropathy

Yukihiko Mashima, Keiko Yamada, Masato Wakakura, Kazuteru Kigasawa, Jun Kudo, Nobuyoshi Shimizu, Yoshihisa Oguchi

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Purpose. To investigate the incidence and clinical significance of primary or proposed secondary mitochondrial DNA (mtDNA) mutations in Japanese patients with Leber's hereditary optic neuropathy (LHON). Methods. Blood samples from the 80 unrelated Japanese patients with bilateral optic atrophy were screened for primary LHON mutations. Patients found to have a primary LHON mutation were then tested for 9 proposed secondary LHON mutations. We investigated the association between these mutations and clinical characteristics. Results. Primary mtDNA mutations were identified in 68 patients: at np 3460 in 3 (4%) of 68 patients, at np 11,778 in 59 patients (87%), and at np 14,484 in 6 patients (9%). We identified 5 secondary mtDNA mutations (at np 3394, 4216, 7444, 9438 or 13,708) in 10 (15%) of 68 LHON patients and 3 mutations (at np 3394, 4216 or 3708) in 6 (7%) of 90 healthy Japanese individuals. No patient was positive for more than one secondary mutation. The frequency of secondary mutations was similar in the 68 LHON patients and 90 controls. The clinical features of the Japanese patients with any of the 3 primary LHON mutations were similar to those of Caucasian patients, despite different mtDNA backgrounds in these populations. The percentage of patients with familial LHON harboring the 3460 or 14,484 mutations was lower in the Japanese population. Conclusions. Japanese patients with LHON exhibited a very high incidence (87%) of the 11,778 primary mutation. Most of the proposed secondary LHON mutations were rare in the Japanese population and they, except the 7444 mutation, may not influence the clinical features of LHON.

Original languageEnglish
Pages (from-to)403-408
Number of pages6
JournalCurrent Eye Research
Volume17
Issue number4
Publication statusPublished - 1998 Apr

Fingerprint

Leber's Hereditary Optic Atrophy
Mitochondrial DNA
Mutation
Population
Optic Atrophy
Incidence
Mutation Rate

Keywords

  • Japanese
  • Leber's hereditary optic neuropathy
  • Mitochondrial DNA mutations
  • Visual prognosis

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Mashima, Y., Yamada, K., Wakakura, M., Kigasawa, K., Kudo, J., Shimizu, N., & Oguchi, Y. (1998). Spectrum of pathogenic mitochondrial DNA mutations and clinical features in Japanese families with Leber's hereditary optic neuropathy. Current Eye Research, 17(4), 403-408.

Spectrum of pathogenic mitochondrial DNA mutations and clinical features in Japanese families with Leber's hereditary optic neuropathy. / Mashima, Yukihiko; Yamada, Keiko; Wakakura, Masato; Kigasawa, Kazuteru; Kudo, Jun; Shimizu, Nobuyoshi; Oguchi, Yoshihisa.

In: Current Eye Research, Vol. 17, No. 4, 04.1998, p. 403-408.

Research output: Contribution to journalArticle

Mashima, Y, Yamada, K, Wakakura, M, Kigasawa, K, Kudo, J, Shimizu, N & Oguchi, Y 1998, 'Spectrum of pathogenic mitochondrial DNA mutations and clinical features in Japanese families with Leber's hereditary optic neuropathy', Current Eye Research, vol. 17, no. 4, pp. 403-408.
Mashima, Yukihiko ; Yamada, Keiko ; Wakakura, Masato ; Kigasawa, Kazuteru ; Kudo, Jun ; Shimizu, Nobuyoshi ; Oguchi, Yoshihisa. / Spectrum of pathogenic mitochondrial DNA mutations and clinical features in Japanese families with Leber's hereditary optic neuropathy. In: Current Eye Research. 1998 ; Vol. 17, No. 4. pp. 403-408.
@article{b364e704118d4b5b89dedd0bf04ce756,
title = "Spectrum of pathogenic mitochondrial DNA mutations and clinical features in Japanese families with Leber's hereditary optic neuropathy",
abstract = "Purpose. To investigate the incidence and clinical significance of primary or proposed secondary mitochondrial DNA (mtDNA) mutations in Japanese patients with Leber's hereditary optic neuropathy (LHON). Methods. Blood samples from the 80 unrelated Japanese patients with bilateral optic atrophy were screened for primary LHON mutations. Patients found to have a primary LHON mutation were then tested for 9 proposed secondary LHON mutations. We investigated the association between these mutations and clinical characteristics. Results. Primary mtDNA mutations were identified in 68 patients: at np 3460 in 3 (4{\%}) of 68 patients, at np 11,778 in 59 patients (87{\%}), and at np 14,484 in 6 patients (9{\%}). We identified 5 secondary mtDNA mutations (at np 3394, 4216, 7444, 9438 or 13,708) in 10 (15{\%}) of 68 LHON patients and 3 mutations (at np 3394, 4216 or 3708) in 6 (7{\%}) of 90 healthy Japanese individuals. No patient was positive for more than one secondary mutation. The frequency of secondary mutations was similar in the 68 LHON patients and 90 controls. The clinical features of the Japanese patients with any of the 3 primary LHON mutations were similar to those of Caucasian patients, despite different mtDNA backgrounds in these populations. The percentage of patients with familial LHON harboring the 3460 or 14,484 mutations was lower in the Japanese population. Conclusions. Japanese patients with LHON exhibited a very high incidence (87{\%}) of the 11,778 primary mutation. Most of the proposed secondary LHON mutations were rare in the Japanese population and they, except the 7444 mutation, may not influence the clinical features of LHON.",
keywords = "Japanese, Leber's hereditary optic neuropathy, Mitochondrial DNA mutations, Visual prognosis",
author = "Yukihiko Mashima and Keiko Yamada and Masato Wakakura and Kazuteru Kigasawa and Jun Kudo and Nobuyoshi Shimizu and Yoshihisa Oguchi",
year = "1998",
month = "4",
language = "English",
volume = "17",
pages = "403--408",
journal = "Current Eye Research",
issn = "0271-3683",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Spectrum of pathogenic mitochondrial DNA mutations and clinical features in Japanese families with Leber's hereditary optic neuropathy

AU - Mashima, Yukihiko

AU - Yamada, Keiko

AU - Wakakura, Masato

AU - Kigasawa, Kazuteru

AU - Kudo, Jun

AU - Shimizu, Nobuyoshi

AU - Oguchi, Yoshihisa

PY - 1998/4

Y1 - 1998/4

N2 - Purpose. To investigate the incidence and clinical significance of primary or proposed secondary mitochondrial DNA (mtDNA) mutations in Japanese patients with Leber's hereditary optic neuropathy (LHON). Methods. Blood samples from the 80 unrelated Japanese patients with bilateral optic atrophy were screened for primary LHON mutations. Patients found to have a primary LHON mutation were then tested for 9 proposed secondary LHON mutations. We investigated the association between these mutations and clinical characteristics. Results. Primary mtDNA mutations were identified in 68 patients: at np 3460 in 3 (4%) of 68 patients, at np 11,778 in 59 patients (87%), and at np 14,484 in 6 patients (9%). We identified 5 secondary mtDNA mutations (at np 3394, 4216, 7444, 9438 or 13,708) in 10 (15%) of 68 LHON patients and 3 mutations (at np 3394, 4216 or 3708) in 6 (7%) of 90 healthy Japanese individuals. No patient was positive for more than one secondary mutation. The frequency of secondary mutations was similar in the 68 LHON patients and 90 controls. The clinical features of the Japanese patients with any of the 3 primary LHON mutations were similar to those of Caucasian patients, despite different mtDNA backgrounds in these populations. The percentage of patients with familial LHON harboring the 3460 or 14,484 mutations was lower in the Japanese population. Conclusions. Japanese patients with LHON exhibited a very high incidence (87%) of the 11,778 primary mutation. Most of the proposed secondary LHON mutations were rare in the Japanese population and they, except the 7444 mutation, may not influence the clinical features of LHON.

AB - Purpose. To investigate the incidence and clinical significance of primary or proposed secondary mitochondrial DNA (mtDNA) mutations in Japanese patients with Leber's hereditary optic neuropathy (LHON). Methods. Blood samples from the 80 unrelated Japanese patients with bilateral optic atrophy were screened for primary LHON mutations. Patients found to have a primary LHON mutation were then tested for 9 proposed secondary LHON mutations. We investigated the association between these mutations and clinical characteristics. Results. Primary mtDNA mutations were identified in 68 patients: at np 3460 in 3 (4%) of 68 patients, at np 11,778 in 59 patients (87%), and at np 14,484 in 6 patients (9%). We identified 5 secondary mtDNA mutations (at np 3394, 4216, 7444, 9438 or 13,708) in 10 (15%) of 68 LHON patients and 3 mutations (at np 3394, 4216 or 3708) in 6 (7%) of 90 healthy Japanese individuals. No patient was positive for more than one secondary mutation. The frequency of secondary mutations was similar in the 68 LHON patients and 90 controls. The clinical features of the Japanese patients with any of the 3 primary LHON mutations were similar to those of Caucasian patients, despite different mtDNA backgrounds in these populations. The percentage of patients with familial LHON harboring the 3460 or 14,484 mutations was lower in the Japanese population. Conclusions. Japanese patients with LHON exhibited a very high incidence (87%) of the 11,778 primary mutation. Most of the proposed secondary LHON mutations were rare in the Japanese population and they, except the 7444 mutation, may not influence the clinical features of LHON.

KW - Japanese

KW - Leber's hereditary optic neuropathy

KW - Mitochondrial DNA mutations

KW - Visual prognosis

UR - http://www.scopus.com/inward/record.url?scp=0031965731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031965731&partnerID=8YFLogxK

M3 - Article

C2 - 9561832

AN - SCOPUS:0031965731

VL - 17

SP - 403

EP - 408

JO - Current Eye Research

JF - Current Eye Research

SN - 0271-3683

IS - 4

ER -